33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-4.29%
Both companies show declining cash positions (-4.29% vs PATH's -6.46%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
9.15%
Short-term investments yoy growth below half of PATH's 32.22%. Michael Burry might see potential liquidity risk. Investigate alternative capital uses or constraints.
5.24%
Cash + STI yoy ≥ 1.5x PATH's 1.35%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
-16.52%
Receivables growth 50-75% of PATH's -31.94%. Bruce Berkowitz would note relatively tighter receivables. Check if sales remain robust.
-20.13%
Inventory growth below half of PATH's 6.95%. David Dodd would check if that's due to efficiency or supply constraints.
5.15%
Other current assets growth < half of PATH's 27.47%. David Dodd sees a leaner approach to short-term items.
1.36%
Below half of PATH's -3.72%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-9.20%
≥ 1.5x PATH's -2.36%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
10.28%
Less than half of PATH's -8.01%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
10.28%
Less than half of PATH's -0.58%. David Dodd sees fewer intangible expansions vs. competitor. Possibly safer balance sheet.
-22.40%
Below half of PATH's 94.09%. Michael Burry sees possible underinvestment in long-term assets. Verify capital constraints.
-10.28%
Less than half of PATH's 0.34%. David Dodd sees fewer tax deferrals or losses, indicating stronger profitability vs. competitor.
2.58%
Less than half of PATH's -2.96%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-4.77%
≥ 1.5x PATH's -1.38%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
-1.14%
Below half of PATH's -3.38%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-3.00%
Less than half of PATH's -35.51%. David Dodd sees a more disciplined AP approach or lower volume.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.34%
Below half of PATH's -3.12%. Michael Burry suspects a big gap in pre-sales traction.
-15.37%
Similar yoy changes to PATH's -18.60%. Walter Schloss finds parallel near-term liability trends.
-0.29%
Less than half of PATH's -19.64%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
3.44%
Below half PATH's -6.96%. Michael Burry suspects a serious gap in multi-year pipeline.
No Data
No Data available this quarter, please select a different quarter.
-4.53%
Less than half of PATH's 33.60%. David Dodd notes more conservative expansions in non-current obligations.
-0.74%
Less than half of PATH's -2.57%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
-0.45%
Less than half of PATH's -15.69%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-5.81%
≥ 1.5x PATH's -1.75%. David Dodd sees higher yoy retained profits than competitor.
-146.32%
Less than half of PATH's 32.34%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.64%
Below half PATH's 1.84%. Michael Burry sees potential underperformance in building shareholder capital.
-1.14%
Below half PATH's -3.38%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
3.22%
Below half PATH's 31.13%. Michael Burry suspects major underinvestment or forced divestment.
-14.27%
1.25-1.5x PATH's -10.84%. Martin Whitman is wary of bigger debt expansions vs. competitor.
-11.48%
Less than half of PATH's 6.25%. David Dodd sees better deleveraging or stronger cash buildup than competitor.